CGC Quote, Financials, Valuation and Earnings

Milestone Pharmaceuticals, Inc. has a net margin of -2.46% compared to Canopy Growth Corp.'s net margin of --. Canopy Growth Corp.'s return on equity of -67.7% beat Milestone Pharmaceuticals, Inc.'s return on equity of -858.37%.

Canopy Growth Corp. has a consensus price target of $3.64, signalling upside risk potential of 175.94%. On the other hand Milestone Pharmaceuticals, Inc. has an analysts' consensus of $6.60 which suggests that it could grow by 218.84%. Given that Milestone Pharmaceuticals, Inc. has higher upside potential than Canopy Growth Corp., analysts believe Milestone Pharmaceuticals, Inc. is more attractive than Canopy Growth Corp..

Canopy Growth Corp. has a beta of 0.403, which suggesting that the stock is 59.734% less volatile than S&P 500. In comparison Milestone Pharmaceuticals, Inc. has a beta of 0.408, suggesting its less volatile than the S&P 500 by 59.159%.

Canopy Growth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Canopy Growth Corp. pays -- of its earnings as a dividend. Milestone Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.

Canopy Growth Corp. quarterly revenues are $48.4M, which are larger than Milestone Pharmaceuticals, Inc. quarterly revenues of --. Canopy Growth Corp.'s net income of -$1.2M is higher than Milestone Pharmaceuticals, Inc.'s net income of -$11.9M. Notably, Canopy Growth Corp.'s price-to-earnings ratio is -- while Milestone Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Canopy Growth Corp. is 1.20x versus -- for Milestone Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Oncolytics Biotech, Inc. has a net margin of -2.46% compared to Canopy Growth Corp.'s net margin of --. Canopy Growth Corp.'s return on equity of -67.7% beat Oncolytics Biotech, Inc.'s return on equity of -635.07%.

Canopy Growth Corp. has a consensus price target of $3.64, signalling upside risk potential of 175.94%. On the other hand Oncolytics Biotech, Inc. has an analysts' consensus of $5.55 which suggests that it could grow by 473.15%. Given that Oncolytics Biotech, Inc. has higher upside potential than Canopy Growth Corp., analysts believe Oncolytics Biotech, Inc. is more attractive than Canopy Growth Corp..

Canopy Growth Corp. has a beta of 0.403, which suggesting that the stock is 59.734% less volatile than S&P 500. In comparison Oncolytics Biotech, Inc. has a beta of 0.880, suggesting its less volatile than the S&P 500 by 11.965%.

Canopy Growth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oncolytics Biotech, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Canopy Growth Corp. pays -- of its earnings as a dividend. Oncolytics Biotech, Inc. pays out -- of its earnings as a dividend.

Canopy Growth Corp. quarterly revenues are $48.4M, which are larger than Oncolytics Biotech, Inc. quarterly revenues of --. Canopy Growth Corp.'s net income of -$1.2M is higher than Oncolytics Biotech, Inc.'s net income of -$10.5M. Notably, Canopy Growth Corp.'s price-to-earnings ratio is -- while Oncolytics Biotech, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Canopy Growth Corp. is 1.20x versus -- for Oncolytics Biotech, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Tilray Brands, Inc. has a net margin of -2.46% compared to Canopy Growth Corp.'s net margin of 0.72%. Canopy Growth Corp.'s return on equity of -67.7% beat Tilray Brands, Inc.'s return on equity of -84.8%.

Canopy Growth Corp. has a consensus price target of $3.64, signalling upside risk potential of 175.94%. On the other hand Tilray Brands, Inc. has an analysts' consensus of $16.17 which suggests that it could grow by 55.15%. Given that Canopy Growth Corp. has higher upside potential than Tilray Brands, Inc., analysts believe Canopy Growth Corp. is more attractive than Tilray Brands, Inc..

Canopy Growth Corp. has a beta of 0.403, which suggesting that the stock is 59.734% less volatile than S&P 500. In comparison Tilray Brands, Inc. has a beta of 1.758, suggesting its more volatile than the S&P 500 by 75.794%.

Canopy Growth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tilray Brands, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Canopy Growth Corp. pays -- of its earnings as a dividend. Tilray Brands, Inc. pays out -- of its earnings as a dividend.

Canopy Growth Corp. quarterly revenues are $48.4M, which are smaller than Tilray Brands, Inc. quarterly revenues of $209.5M. Canopy Growth Corp.'s net income of -$1.2M is lower than Tilray Brands, Inc.'s net income of $1.5M. Notably, Canopy Growth Corp.'s price-to-earnings ratio is -- while Tilray Brands, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Canopy Growth Corp. is 1.20x versus 3.64x for Tilray Brands, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Venus Concept, Inc. has a net margin of -2.46% compared to Canopy Growth Corp.'s net margin of -163.68%. Canopy Growth Corp.'s return on equity of -67.7% beat Venus Concept, Inc.'s return on equity of -1236.95%.

Canopy Growth Corp. has a consensus price target of $3.64, signalling upside risk potential of 175.94%. On the other hand Venus Concept, Inc. has an analysts' consensus of -- which suggests that it could grow by 6102.13%. Given that Venus Concept, Inc. has higher upside potential than Canopy Growth Corp., analysts believe Venus Concept, Inc. is more attractive than Canopy Growth Corp..

Canopy Growth Corp. has a beta of 0.403, which suggesting that the stock is 59.734% less volatile than S&P 500. In comparison Venus Concept, Inc. has a beta of -0.111, suggesting its less volatile than the S&P 500 by 111.094%.

Canopy Growth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Venus Concept, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Canopy Growth Corp. pays -- of its earnings as a dividend. Venus Concept, Inc. pays out -- of its earnings as a dividend.

Canopy Growth Corp. quarterly revenues are $48.4M, which are larger than Venus Concept, Inc. quarterly revenues of $13.8M. Canopy Growth Corp.'s net income of -$1.2M is higher than Venus Concept, Inc.'s net income of -$22.5M. Notably, Canopy Growth Corp.'s price-to-earnings ratio is -- while Venus Concept, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Canopy Growth Corp. is 1.20x versus 0.04x for Venus Concept, Inc.. Usually stocks with elevated PS ratios are considered overvalued.